S2213, ?A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (DARA-VCD) Induction Followed by Autologous Stem Cell Transplant or DARA-VCD Consolidation and Daratumumab Maintenance in patients with Newly Diagnose

    Project: Non Profit

    Project Details

    StatusActive
    Effective start/end date12/1/23 → 11/30/32